These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

595 related articles for article (PubMed ID: 11389039)

  • 1. Human cathelicidin, hCAP-18, is processed to the antimicrobial peptide LL-37 by extracellular cleavage with proteinase 3.
    Sørensen OE; Follin P; Johnsen AH; Calafat J; Tjabringa GS; Hiemstra PS; Borregaard N
    Blood; 2001 Jun; 97(12):3951-9. PubMed ID: 11389039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The human antibacterial cathelicidin, hCAP-18, is synthesized in myelocytes and metamyelocytes and localized to specific granules in neutrophils.
    Sørensen O; Arnljots K; Cowland JB; Bainton DF; Borregaard N
    Blood; 1997 Oct; 90(7):2796-803. PubMed ID: 9326247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The human antibacterial cathelicidin, hCAP-18, is bound to lipoproteins in plasma.
    Sørensen O; Bratt T; Johnsen AH; Madsen MT; Borregaard N
    J Biol Chem; 1999 Aug; 274(32):22445-51. PubMed ID: 10428818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sorting of neutrophil-specific granule protein human cathelicidin, hCAP-18, when constitutively expressed in myeloid cells.
    Bülow E; Bengtsson N; Calafat J; Gullberg U; Olsson I
    J Leukoc Biol; 2002 Jul; 72(1):147-53. PubMed ID: 12101274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Papillon-Lefèvre syndrome patient reveals species-dependent requirements for neutrophil defenses.
    Sørensen OE; Clemmensen SN; Dahl SL; Østergaard O; Heegaard NH; Glenthøj A; Nielsen FC; Borregaard N
    J Clin Invest; 2014 Oct; 124(10):4539-48. PubMed ID: 25244098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cathelicidins: a family of endogenous antimicrobial peptides.
    Lehrer RI; Ganz T
    Curr Opin Hematol; 2002 Jan; 9(1):18-22. PubMed ID: 11753073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Processing of seminal plasma hCAP-18 to ALL-38 by gastricsin: a novel mechanism of generating antimicrobial peptides in vagina.
    Sørensen OE; Gram L; Johnsen AH; Andersson E; Bangsbøll S; Tjabringa GS; Hiemstra PS; Malm J; Egesten A; Borregaard N
    J Biol Chem; 2003 Aug; 278(31):28540-6. PubMed ID: 12759353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An ELISA for hCAP-18, the cathelicidin present in human neutrophils and plasma.
    Sørensen O; Cowland JB; Askaa J; Borregaard N
    J Immunol Methods; 1997 Aug; 206(1-2):53-9. PubMed ID: 9328568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The heterogeneity of azurophil granules in neutrophil promyelocytes: immunogold localization of myeloperoxidase, cathepsin G, elastase, proteinase 3, and bactericidal/permeability increasing protein.
    Egesten A; Breton-Gorius J; Guichard J; Gullberg U; Olsson I
    Blood; 1994 May; 83(10):2985-94. PubMed ID: 8180395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transient cutaneous adenoviral gene therapy with human host defense peptide hCAP-18/LL-37 is effective for the treatment of burn wound infections.
    Jacobsen F; Mittler D; Hirsch T; Gerhards A; Lehnhardt M; Voss B; Steinau HU; Steinstraesser L
    Gene Ther; 2005 Oct; 12(20):1494-502. PubMed ID: 15973442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial peptide hCAP-18/LL-37 protein and mRNA expressions in different periodontal diseases.
    Türkoğlu O; Kandiloğlu G; Berdeli A; Emingil G; Atilla G
    Oral Dis; 2011 Jan; 17(1):60-7. PubMed ID: 20646232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vesicular LL-37 contributes to inflammation of the lesional skin of palmoplantar pustulosis.
    Murakami M; Kaneko T; Nakatsuji T; Kameda K; Okazaki H; Dai X; Hanakawa Y; Tohyama M; Ishida-Yamamoto A; Sayama K
    PLoS One; 2014; 9(10):e110677. PubMed ID: 25330301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Localization of hCAP-18 on the surface of chemoattractant-stimulated human granulocytes: analysis using two novel hCAP-18-specific monoclonal antibodies.
    Stie J; Jesaitis AV; Lord CI; Gripentrog JM; Taylor RM; Burritt JB; Jesaitis AJ
    J Leukoc Biol; 2007 Jul; 82(1):161-72. PubMed ID: 17400609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The human cathelicidin LL-37: a multifunctional peptide involved in infection and inflammation in the lung.
    Tjabringa GS; Rabe KF; Hiemstra PS
    Pulm Pharmacol Ther; 2005; 18(5):321-7. PubMed ID: 15939310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary defense and the human cathelicidin hCAP-18/LL-37.
    Fahy RJ; Wewers MD
    Immunol Res; 2005; 31(2):75-89. PubMed ID: 15778507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LL-37 complexation with glycosaminoglycans in cystic fibrosis lungs inhibits antimicrobial activity, which can be restored by hypertonic saline.
    Bergsson G; Reeves EP; McNally P; Chotirmall SH; Greene CM; Greally P; Murphy P; O'Neill SJ; McElvaney NG
    J Immunol; 2009 Jul; 183(1):543-51. PubMed ID: 19542465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toll-like receptor activation modulates antimicrobial peptide expression by ocular surface cells.
    Redfern RL; Reins RY; McDermott AM
    Exp Eye Res; 2011 Mar; 92(3):209-20. PubMed ID: 21195713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Azurocidin and a homologous serine protease from neutrophils. Differential antimicrobial and proteolytic properties.
    Campanelli D; Detmers PA; Nathan CF; Gabay JE
    J Clin Invest; 1990 Mar; 85(3):904-15. PubMed ID: 2312733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salivary mucins inhibit antibacterial activity of the cathelicidin-derived LL-37 peptide but not the cationic steroid CSA-13.
    Bucki R; Namiot DB; Namiot Z; Savage PB; Janmey PA
    J Antimicrob Chemother; 2008 Aug; 62(2):329-35. PubMed ID: 18456648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial and protease inhibitory functions of the human cathelicidin (hCAP18/LL-37) prosequence.
    Zaiou M; Nizet V; Gallo RL
    J Invest Dermatol; 2003 May; 120(5):810-6. PubMed ID: 12713586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.